Enrollment begins for study on Orthofix's RCStim device for rotator cuff repair — 5 insights

Written by Megan Wood | February 13, 2018 | Print  |

Enrollment started for a study testing Orthofix's RCStim device as an adjunctive treatment to surgically mending full thickness rotator cuff tears.

Here are five insights:


1. Researchers will assess whether pulsed electromagnetic field technology is able to decrease the rate of repaired tendons undergoing subsequent tears.


2. Additionally, the study will examine if a correlation exists between PEMF treatment and enhanced muscle strength, range of motion and decreased pain scores.


3. The study will include about 538 patients between the ages of 21 and 80, followed for 24 months post-treatment.


4. Up to 30 U.S. sites will participate in the study.


5. The RCStim is an investigational device.


More articles on devices:
Medtronic hires director of finance: 4 things to know
Camber Spine highlights 1st procedures with SPIRA-C Open Matrix Cervical Interbody — 5 notes
Can Johnson & Johnson become a 132-year-old healthcare startup? 5 quotes from CEO Alex Gorsky


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months